Centchroman Versus Tamoxifen for the Management of Mastalgia: A Randomised Controlled Trial - Nil

on-funded0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1. All female patients, aged >18 years
•2. Patients, who have complain of mastalgia with or without breast fibroadenoma having persistent symptoms for more than 1 month after reassurance and supportive breast management.
•3. Pain severity of >3/10 on visual analog scale.

•1. Acute inflammatory breast conditions (cellulitis , breast abscess)
•2. suspicion of malignancy ( clinical or radiological)
•3. Family history of breast and ovarian carcinoma
•4. Contraindication to centchroman and tamoxifen —--
•a.Pregnancy
•b.Polycystic ovarian diseases ( PCOD )
•c.Cervical hyperplasia do
•d.Recent history or clinical evidence of jaundice or liver diseases
•e Conditions like, chronic illness such as tuberculosis, renal diseases, severe allergic states etc.
•f.Patients willing to conceive within six months.
•5.History of chest trauma
•6.Severe drug reaction to either centchroman or tamoxifen after starting treatment

发起方

on-funded